SBC Medical Group Holdings formed a capital and business partnership with Taiwan-based NeuroBrain Dynamics (NBD) on November 13, 2026. SBC took a minority stake in NeuroBrain Dynamics. The medical services organization supports 287 clinics in Japan and overseas.
Partnership scope
The companies will co-develop AI tools on NBD's Argon platform. SBC gains priority sales rights for NBD products in Japan and South Korea. It also receives exclusive use of the co-developed solutions in those markets.
NBD's regional footprint
NeuroBrain Dynamics was founded in June 2024 and is based in Taipei. The firm reports AI deployments at more than 100 companies across the Asia-Pacific region. It also has teams in 7 Asia-Pacific cities.
What the AI tools do
The planned solutions include a concierge recommendation tool and personalized suggestions inside the MySBC booking system. Other tools support voice-based charting, shift scheduling, and promotional image generation. SBC also plans to use Bromine monitoring and a private large language model base for security.
SBC will begin verification of AI voice charting in orthopedic care and aims to complete a proof of concept by the end of 2026. A phased group rollout is expected around mid-2027, beginning with the concierge tool, MySBC recommendations, and the Clinic Promotion Planner. The companies then plan to expand the solutions through B2B sales across Asia.